Wason

A multi-stage drop-the-losers design for multi-arm clinical trials

*Statistical Methods in Medical Research* 2017; 26(1):508-524

Recent Developments in Group-Sequential Designs

In *Developments in Statistical Evaluation of Clinical Trials* 97-118

Correcting for multiple-testing in multi-arm trials: Is it necessary and is it done?

*Trials* 2014; 15:364

Comment on: Month of birth and risk of multiple sclerosis: Confounding and adjustments

*Annals of Clinical and Translational Neurology* 2014; 1(5):375

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

*British Journal of Cancer* 2014; 110:1950-1957

A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials

*Statistics in Medicine* 2014; 33(13):2206-2221

Reducing the average number of patients needed in a phase II trial through novel design

*Clinical Research and Regulatory Affairs* 2013; 30(4):47-54

Evaluation of multisystemic therapy pilot services in the Systemic Therapy for At Risk Teens (START) trial: Study protocol for a randomised controlled trial

*Trials* 2013; 14:265

Confounding underlies the apparent month of birth effect in multiple sclerosis

*Annals of Neurology* 2013; 73(6):714–720

Using continuous data on tumour measurements to improve inference in phase II cancer studies

*Statistics in Medicine* 2013; 32(26):4639-4650